Zhejiang International Group Company Limited operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang International Group Company Limited with three other
companies in this sector in China:
Yunnan Baiyao Group Co., Ltd.
sales of 20.74 billion Chinese Renmimbi [US$3.03 billion]
of which 56%
was Comodities Trading),
China Medicine Health Industry Co Ltd
(20.56 billion Chinese Renmimbi [US$3.01 billion]
of which 48%
was Pharmaceutical Business-pure/simple vend), and
China National Medicines Corp., Ltd.
(12.08 billion Chinese Renmimbi [US$1.77 billion]
of which 97%
was business department).
Zhejiang International Group Company Limited reported sales of 15.46 billion Chinese Renmimbi (US$2.26 billion)
December of 2015.
increase of 9.9%
versus 2014, when the company's sales were 14.07 billion Chinese Renmimbi.
Sales at Zhejiang International Group Company Limited have increased during each of the previous five years
(and since 2010, sales have increased a total of 133%).
Sales of Other Operations saw an increase
that was more than double the company's growth rate: sales were up
28.2% in 2015, from
27.85 million Chinese Renmimbi to 35.72 million Chinese Renmimbi.